Refine
Has Fulltext
- yes (82)
Is part of the Bibliography
- yes (82)
Year of publication
- 2017 (82) (remove)
Document Type
- Journal article (65)
- Doctoral Thesis (17)
Keywords
- biology (8)
- Apis mellifera (4)
- Trypanosoma (4)
- ants (4)
- social systems (4)
- Drosophila (3)
- Drosophila melanogaster (3)
- animal sociality (3)
- fungi (3)
- symbiosis (3)
- Biology (2)
- Chlamydia trachomatis (2)
- DNA damage (2)
- DNA methylation (2)
- Latrophilin (2)
- Neisseria (2)
- Trypanosoma brucei (2)
- carbon dioxide (2)
- cell differentiation (2)
- ceramide (2)
- chemotherapy (2)
- comparative genomics (2)
- cytokines (2)
- fibroblasts (2)
- foraging (2)
- genetic variation (2)
- humidity (2)
- learning (2)
- lung cancer (2)
- memory (2)
- metabolism (2)
- methylation (2)
- mushroom bodies (2)
- nesting habits (2)
- pollen (2)
- toxins (2)
- 3D Ko-kulture (1)
- 3D cell culture (1)
- 3D-Zellkulturen (Krebstherapie) (1)
- 5-fluorouracil (1)
- Acyrthosiphon pisum (1)
- Adhesion-GPCR (1)
- Agrobacterium vitis (1)
- Angewandte Mikrobiologie (1)
- Angiotensin II (1)
- Angiotensin II Typ 1a-Rezeptor (1)
- Antimikrobieller Wirkstoff (1)
- Apoptosis (1)
- Aspergillus fumigatus (1)
- B cell receptors (1)
- B cells (1)
- BMP (1)
- BRAF inhibition (1)
- Bauchspeicheldrüsenkrebs (1)
- Bruchpilot (1)
- Burkina Faso (1)
- CHO cell culture (1)
- CHO-Zelle (1)
- Caenorhabditis elegans (1)
- Cell surface proteomics (1)
- Chlamydia (1)
- Circadian rhythms and sleep (1)
- CoA (1)
- Complexin (1)
- Computer software (1)
- DNA Barcoding (1)
- DNS-Schädigung (1)
- DREAM complex (1)
- Detektion (1)
- Diagnostik (1)
- Drugtargets (1)
- Dunce isoforms (1)
- EZH2 (1)
- Enzyme Regulation (1)
- Enzyme kinetics (1)
- Enzyme metabolism (1)
- Enzyme regulation (1)
- Enzymes (1)
- Epicardium-derived cells (1)
- Epigenetics (1)
- Exposure Risk (1)
- Fibroblasten (1)
- GPCR (1)
- Genetics (1)
- Genexpression <Molekulargenetik> (1)
- Geschlechtsbestimmung (1)
- Geschlechtsdifferenzierung (1)
- HECT Ligase (1)
- HUWE1 (1)
- Holobiont (1)
- Human atrial stromal cells (1)
- Immune Escape (1)
- Interaktionen (1)
- Japankärpfling (1)
- K-Ras (1)
- Kryptolebias marmoratus (1)
- Landschaftsstruktur (1)
- Lungenkrebs (1)
- MAP-Kinase (1)
- MICA (1)
- MICB (1)
- MITE (1)
- MMB (1)
- Mcl-1 (1)
- Medaka (1)
- Medicine (1)
- Megalobrama amblycephala (1)
- Megaponera analis (1)
- Meiose (1)
- Meiosis (1)
- Melanom (1)
- Meliponini (1)
- Merkel cell carcinoma (1)
- Merkel-Zellkarzinom (1)
- Metabolic pathways (1)
- Mikrobiota (1)
- Mitose (1)
- Molecular Biophysics (1)
- Molekulare Hybridisierung (1)
- Monozytendifferenzierung (1)
- N-terminal domain (1)
- NAD (1)
- NADPH oxidase (1)
- NADPH-Oxidase (1)
- NFATc1 (1)
- Neisseria gonorrhoeae (1)
- Neisseria meningitidis (1)
- Neuromuscular junctions (1)
- Next-Generation Sequenzierung (1)
- Nicht-kleinzelliges Bronchialkarzinom (NSCLC) (1)
- Nährboden (1)
- OGEE v2 (1)
- Oilseed Rape (1)
- Oxidativer Stress (1)
- P14ARF (1)
- PDE4d (1)
- PER (1)
- Pipecolinsäurederivate (1)
- Pollen (1)
- Predictive toxicology (1)
- Produktivität (1)
- RNA in situ hybridization (1)
- RNA interference (1)
- Resource Use (1)
- Retinoesäure (1)
- Retinoic acid (1)
- Saccharomyces cerevisiae (1)
- Sammeldistanzen (1)
- Senescence (1)
- Septins (1)
- Sex determination (1)
- Staphylococcus aureus (1)
- Stoffwechsel (1)
- Structural Biology (1)
- Synapse (1)
- Synapses (1)
- Synaptic vesicles (1)
- Systembiologie (1)
- Systembiologische Analysen (1)
- T cells (1)
- T-cadherin (1)
- TAMs (1)
- TP53 (1)
- Telomer (1)
- Toxicity (1)
- Transcriptional control (1)
- Tumor Immunology (1)
- Ubiquitin (1)
- Vaccinia virus (1)
- Vesicles (1)
- Weinrebe (1)
- Wilms tumour (1)
- Wurzelhalsgalle (1)
- X-Ray Chrystallography (1)
- Zea mays (1)
- Zebrafish (1)
- Zellkultur (1)
- Zytokinine (Pflanzenpathogene) (1)
- active zone (1)
- acute myeloid leukaemia (1)
- adhesion GPCR (1)
- agroecology (1)
- alcohol tolerance (1)
- alkaloids (1)
- alu elements (1)
- anaplasia (1)
- angiotensin II type 1a receptor (1)
- antibiotics (1)
- antimicrobials (1)
- bakterielle Flora (1)
- bees (1)
- behavior (1)
- behavioural ecology (1)
- biogenic amines (1)
- bioinformatics (1)
- biomarker (1)
- biomaterials (1)
- biophysics (1)
- blood (1)
- blood platelets (1)
- bone (1)
- brain (1)
- brain development (1)
- breast cancer (1)
- cadherin-13 (CDH13) (1)
- cancer (1)
- cancer treatment (1)
- cash crops (1)
- catabolism (1)
- cell binding (1)
- cell cycle (1)
- cell cycle and cell division (1)
- cell proliferation (1)
- cell-autonomous defense (1)
- cellular function (1)
- cellular stress (1)
- central clocks (1)
- central complex (1)
- ceramide analogs (1)
- cholera (1)
- chromatin remodeling (1)
- chronobiology (1)
- circadian clock (1)
- circadian mechanisms (1)
- clinical genetics (1)
- cloning (1)
- cognition (1)
- colorectal carcinoma (1)
- compound conditioning (1)
- confocal laser scanning microscopy (1)
- confocal-microscopy based automated quantification (1)
- cotton (1)
- crotonase (1)
- cryptic (1)
- cytokinesis (1)
- cytotoxic T cells (1)
- dCIRL (1)
- damped circadian clock (1)
- decision-making (1)
- deformed wing virus (1)
- dehydrogenase (1)
- desert ants (1)
- deubiquitinase (1)
- developmental differentiation (1)
- differential olfactory conditioning (1)
- division of labor (1)
- dorsal raphe (1)
- dunce (1)
- eEF1A1 (1)
- eclosion (1)
- ecological genetics (1)
- ecosystem services (1)
- endophyte (1)
- epigenetics (1)
- eukaryota (1)
- evolutionary genetics (1)
- evolutionary response (1)
- fetal cord blood (1)
- fetal programming (1)
- floral resource distribution (1)
- fluorescence imaging (1)
- forager (1)
- foraging behaviour (1)
- foraging distances (1)
- functional complementarity (1)
- functional redundancy (1)
- fungal endophytes of grasses (1)
- fungal infection (1)
- fungal physiology (1)
- fungal structure (1)
- gambiense (1)
- gene essentiality database (1)
- gene expression (1)
- gene regulation (1)
- genetic loci (1)
- genome collection (1)
- genome integrity (1)
- genome sequencing (1)
- genomic libraries (1)
- genomic sequence (1)
- genomics research (1)
- gestational diabetes mellitus (1)
- glioblastoma multiforme (1)
- glycoprotein Ib (1)
- glycosylation (1)
- gonococcal (1)
- gonococcal infection (1)
- grass (1)
- gut microflora (1)
- habitat information (1)
- halbnatürliche Habitate (1)
- hangover (1)
- herbivorous diet (1)
- herpes virus (1)
- high throughput (1)
- high-throughput screening (1)
- histones (1)
- honey bees (1)
- honeybees (1)
- human cancer cell lines (1)
- humanized mice (1)
- hyperexpression techniques (1)
- ichthyology (1)
- image analysis (1)
- imaging the immune system (1)
- immune cells (1)
- immune evasion (1)
- infectious diseases (1)
- infectious-disease diagnostics (1)
- infrared radiation (1)
- insect (1)
- insulin treatment (1)
- intermuscular bone (1)
- kinesin (1)
- landscape ecology (1)
- landscape structure (1)
- leaves (1)
- light pulses (1)
- lipids (1)
- look-back behavior (1)
- lymphocyte activation (1)
- macrophages (1)
- mass spectrometry (1)
- mating success (1)
- mechanobiology (1)
- mechanosensing (1)
- mechanotransduction (1)
- media design (1)
- megakaryocytes (1)
- membrane receptor signaling (1)
- messenger RNA (1)
- metabotropic signalling (1)
- metagenomics (1)
- miRNA-Detektion (1)
- miRNS (1)
- microRNAs (1)
- microRNA–target interaction (1)
- microbiome (1)
- microswimmer (1)
- migration (1)
- mitochondria (1)
- mitotic gene expression (1)
- molecular diagnostics (1)
- molecular neuroscience (1)
- molting (1)
- monocyte (1)
- monocyte differentiation (1)
- morphometry (1)
- multiple myeloma (1)
- mushroom body (1)
- natural killer cells (1)
- neisseria meningitidis (1)
- nephroblastoma (1)
- nesting habit (1)
- networks (1)
- neuroanatomy (1)
- neurodevelopment (1)
- neuronal development (1)
- neuropeptide pathway (1)
- next-generation sequencing (1)
- none (1)
- nurse bee (1)
- nutrition (1)
- nutritional ecology (1)
- octopamine (1)
- optogenetics (1)
- orientation (1)
- osteocytes (1)
- oxaliplatin (1)
- oxidative stress (1)
- pancreatic cancer (1)
- parasitic cell cycles (1)
- parasitic diseases (1)
- pattern recognition receptors (1)
- perception (1)
- peripheral clocks (1)
- plant defense (1)
- plant-insect interactions (1)
- plant–insect interactions (1)
- point-of-care (1)
- pollination (1)
- pollinator decline (1)
- population structure (1)
- prefrontal cortex (1)
- proGenomes (1)
- proboscis extension reflex (1)
- product qualitymodulation (1)
- prokaryotic clade (1)
- prokaryotic subspecies (1)
- protein structure (1)
- proteins (1)
- proteomes (1)
- psychiatric disorders (1)
- quality control (1)
- radial glia (1)
- reactivating p53 and inducing tumor apoptosis (RITA) (1)
- recruitment (1)
- regulation (1)
- regulatory T cells (1)
- regulatory circuit downstream (1)
- relA (1)
- replication (1)
- reproductive asynchrony (1)
- rescue behavior (1)
- resin (1)
- retinal development (1)
- sacbrood virus (1)
- season (1)
- semi-natural habitat (1)
- sensory physiology (1)
- sept3 (1)
- sept5a (1)
- sept5b (1)
- septin (1)
- sequence assembly tools (1)
- serotonin (1)
- sesame (1)
- sex-specific mortality (1)
- sexual dimorphism in timing (1)
- signal transduction (1)
- signaling (1)
- sky-compass pathway (1)
- sleeping sickness (1)
- small interfering RNAs (1)
- social immunity (1)
- sphingolipids (1)
- sphingomyelinase (1)
- spider (1)
- spidroin (1)
- string database (1)
- stringent response (1)
- structural biology (1)
- substrate channeling (1)
- super-resolution microscopy (1)
- synaptic vesicle tethering (1)
- systems biology (1)
- taxonomic description (1)
- telomere-binding protein (1)
- tetracyclines (1)
- therapeutic strategy (1)
- throat (1)
- transcriptome (1)
- treatment (1)
- tsetse fly (1)
- tumour heterogeneity (1)
- vaccinia virus (1)
- vector navigation (1)
- video recording (1)
- virulenceregulatory evolution (1)
- visual orientation (1)
- whole genome (1)
- yellow fluorescent protein (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (82) (remove)
Sonstige beteiligte Institutionen
Das Renin-Angiotensin-Aldosteron-System (RAAS) reguliert den Blutdruck sowie den Elektrolyt- und Wasserhaushalt. Das aktive Peptid, Angiotensin II (AngII), führt dabei zur Vasokonstriktion und in höheren Konzentrationen zu Bluthochdruck. Hypertensive Patienten haben ein erhöhtes Risiko an Krebs zu erkranken, vor allem an Nierenkrebs. Wir konnten bereits in vivo zeigen, dass AngII in der Lage ist, den Blutdruck zu steigern und dosisabhängig zu DNA-Schäden über den Angiotensin II Typ 1-Rezeptor (AT1R) führt. Ein stimuliertes RAAS kann ferner über die Aktivierung der NADPH-Oxidase, einer Hauptquelle der Generierung reaktiver Sauerstoffspezies (ROS) in der Zelle, zu oxidativem Stress führen. Zielsetzung dieser Arbeit war es zum einen, mit Hilfe von AT1a-Rezeptor-defizienten Mäusen in vivo zu prüfen, ob die Bildung von ROS, sowie die Bildung von DNA-Schäden in der Niere und im Herzen unabhängig von einem erhöhten Blutdruck auftreten. Zum anderen sollte, ebenfalls in vivo, untersucht werden, ob eine oder beide von zwei untersuchten Isoformen der NADPH-Oxidase (Nox) für die Auslösung oxidativen Stresses in der Niere verantwortlich ist.
Zunächst wurden für den Versuch zur Überprüfung der Abhängigkeit AngII-induzierter DNA-Schäden vom Blutdruck männliche C57BL/6-Mäuse und AT1a-Knockout (KO)-Mäuse mit osmotischen Minipumpen ausgestattet, die AngII in einer Konzentrationen von 600 ng/kg min über einen Zeitraum von 28 Tagen abgaben. Zusätzlich wurde eine Gruppe von AngII-behandelten Wildtyp (WT)-Mäusen mit dem AT1-Rezeptor-Blocker Candesartan (Cand) behandelt. Während des Versuchszeitraumes fanden regelmäßige, nicht-invasive Blutdruckmessungen an den wachen Mäusen statt. In WT-Mäusen induzierte AngII Bluthochdruck, verursachte erhöhte Albumin-Level im Urin und führte zur Bildung von ROS in Niere und im Herzen. Außerdem traten in dieser Gruppe DNA-Schäden in Form von Einzel- und Doppelstrangbrüchen auf. All diese Reaktionen auf AngII konnten jedoch durch gleichzeitige Behandlung mit Cand verhindert werden. AT1a-KO-Mäuse hatten, verglichen mit WT-Kontrollmäusen, einen signifikant niedrigeren Blutdruck und normale Albumin-Level im Urin. In AT1a-KO-Mäusen, die mit AngII behandelt wurden, konnte kein Anstieg des systolischen Blutdrucks sowie kein Einfluss auf die Nierenfunktion gefunden werden. Jedoch führte AngII in dieser Gruppe zu einer Steigerung von ROS in der Niere und im Herzen. Zusätzlich wurden genomische Schäden, vor allem in Form von Doppelstrangbrüchen signifikant in dieser Gruppe induziert. Auch wenn AT1a-KO-Tiere, unabhängig von einer AngII-Infusion, keine eingeschränkte Nierenfunktion zeigten, so wiesen sie erhebliche histopathologische Schäden im Hinblick auf die Glomeruli und das Tubulussystem auf. Diese Art von Schäden deuten auf eine besondere Bedeutung des AT1aR im Hinblick auf die embryonale Entwicklung der Niere hin. Zusammenfassend beweisen die Ergebnisse dieses Experiments eindeutig, dass eine AngII-induzierte ROS-Produktion und die Induktion von DNA-Schäden unabhängig von einem erhöhten Blutdruck auftreten. Da in der AngII-behandelten AT1a-KO-Gruppe eine signifikant höhere Expression des AT1b-Rezeptors zu finden war und die Blockade von beiden Rezeptorsubtypen mit Cand zu einer Verhinderung der schädlichen Effekte durch AngII führte, scheint der AT1bR im Falle einer AT1aR-Defizienz für die Entstehung der Schäden zuständig zu sein.
Ziel des zweiten Experimentes war es, den Beitrag der Nox2 und Nox4 zum oxidativen DNA-Schaden in vivo zu untersuchen. Hierfür wurden männliche C57BL/6-Mäuse und Nox2- oder Nox4-defiziente Mäuse mit osmotischen Minipumpen ausgestattet, die AngII in einer Konzentration von 600 ng/kg min über einen Zeitraum von 28 Tagen abgaben. Im WT-Stamm und in beiden Nox-defizienten Stämmen induzierte AngII Bluthochdruck, verursachte erhöhte Albumin-Level im Urin und führte zur Bildung von ROS in der Niere. Außerdem waren in allen AngII-behandelten Gruppen genomische Schäden, vor allem in Form von Doppelstrangbrüchen, erhöht. Auch in Abwesenheit von AngII wiesen Nox2- und Nox4-defiziente Mäuse mehr Doppelstrangbrüche im Vergleich zu WT-Kontrollmäusen auf. Interessanterweise kompensieren allerdings weder Nox2 noch Nox4 das Fehlen der jeweils anderen Isoform auf RNA-Basis. Aufgrund dieser Ergebnisse schließen wir, dass bislang keine Isoform alleine für die Generierung von oxidativen DNA-Schäden in der Niere verantwortlich gemacht werden kann und dass eine Beteiligung einer weiteren Nox-Isoform sehr wahrscheinlich ist. Möglicherweise könnten aber auch andere ROS-generierende Enzyme, wie Xanthinoxidase oder Stickoxidsynthase involviert sein. Da genomische Schäden in Nieren von Nox2- und Nox4-defizienten Mäusen in Abwesenheit von AngII gegenüber den Schäden in WT-Kontrollmäusen erhöht waren, könnten die beiden Isoformen auch eine schützende Funktion im Bereich von Nierenkrankheiten übernehmen. Da dies aber bislang nur für Nox4 beschrieben ist, ist es wahrscheinlicher, dass das Fehlen von einer der beiden Isoformen eher einen Einfluss auf die Embryonalentwicklung hat. Um dies jedoch abschließend zu klären wäre es sinnvoll mit induzierbaren Knockout-Modellen zu arbeiten, bei denen mögliche entwicklungsbedingte Effekte minimiert werden können.
For persistent infections of the mammalian host, African trypanosomes limit their population size by quorum sensing of the parasite-excreted stumpy induction factor (SIF), which induces development to the tsetse-infective stumpy stage. We found that besides this cell density-dependent mechanism, there exists a second path to the stumpy stage that is linked to antigenic variation, the main instrument of parasite virulence. The expression of a second variant surface glycoprotein (VSG) leads to transcriptional attenuation of the VSG expression site (ES) and immediate development to tsetse fly infective stumpy parasites. This path is independent of SIF and solely controlled by the transcriptional status of the ES. In pleomorphic trypanosomes varying degrees of ES-attenuation result in phenotypic plasticity. While full ES-attenuation causes irreversible stumpy development, milder attenuation may open a time window for rescuing an unsuccessful antigenic switch, a scenario that so far has not been considered as important for parasite survival.
Aspergillus (A.) fumigatus is an opportunistic fungal mold inducing invasive aspergillosis (IA) in immunocompromised patients. Although antifungal activity of human natural killer (NK) cells was shown in previous studies, the underlying cellular mechanisms and pathogen recognition receptors (PRRs) are still unknown. Using flow cytometry we were able to show that the fluorescence positivity of the surface receptor CD56 significantly decreased upon fungal contact. To visualize the interaction site of NK cells and A. fumigatus we used SEM, CLSM and dSTORM techniques, which clearly demonstrated that NK cells directly interact with A. fumigatus via CD56 and that CD56 is re-organized and accumulated at this interaction site time-dependently. The inhibition of the cytoskeleton showed that the receptor re-organization was an active process dependent on actin re-arrangements. Furthermore, we could show that CD56 plays a role in the fungus mediated NK cell activation, since blocking of CD56 surface receptor reduced fungal mediated NK cell activation and reduced cytokine secretion. These results confirmed the direct interaction of NK cells and A. fumigatus, leading to the conclusion that CD56 is a pathogen recognition receptor. These findings give new insights into the functional role of CD56 in the pathogen recognition during the innate immune response.
Intracellular pathogenic microorganisms and toxins exploit host cell mechanisms to enter, exert their deleterious effects as well as hijack host nutrition for their development. A potential approach to treat multiple pathogen infections and that should not induce drug resistance is the use of small molecules that target host components. We identifed the compound 1-adamantyl (5-bromo-2-methoxybenzyl) amine (ABMA) from a cell-based high throughput screening for its capacity to protect human cells and mice against ricin toxin without toxicity. This compound efciently protects cells against various toxins and pathogens including viruses, intracellular bacteria and parasite. ABMA provokes Rab7-positive late endosomal compartment accumulation in mammalian cells without affecting other organelles (early endosomes, lysosomes, the Golgi apparatus, the endoplasmic reticulum or the nucleus). As the mechanism of action of ABMA is restricted to host-endosomal compartments, it reduces cell infection by pathogens that depend on this pathway to invade cells. ABMA may represent a novel class of broad-spectrum compounds with therapeutic potential against diverse severe infectious diseases.
The MuvB multiprotein complex, together with B-MYB and FOXM1 (MMB-FOXM1), plays an essential role in cell cycle progression by regulating the transcription of genes required for mitosis and cytokinesis. In many tumors, B-MYB and FOXM1 are overexpressed as part of the proliferation signature. However, the transcriptional targets that are important for oncogenesis have not been identified. Given that mitotic kinesins are highly expressed in cancer cells and that selected kinesins have been reported as target genes of MMB-FOXM1, we sought to determine which mitotic kinesins are directly regulated by MMB-FOXM1. We demonstrate that six mitotic kinesins and two microtubule-associated non-motor proteins (MAPs) CEP55 and PRC1 are direct transcriptional targets of MuvB, B-MYB and FOXM1 in breast cancer cells.
Suppression of KIF23 and PRC1 strongly suppressed proliferation of MDA-MB-231 cells. The set of MMB-FOXM1 regulated kinesins genes and 4 additional kinesins which we referred to as the mitotic kinesin signature (MKS) is linked to poor outcome in breast cancer patients. Thus, mitotic kinesins could be used as prognostic biomarker and could be potential therapeutic targets for the treatment of breast cancer.
Colorectal carcinoma (CRC) is the most common cancer of the gastrointestinal tract with frequently dysregulated intracellular signaling pathways, including p53 signaling. The mainstay of chemotherapy treatment of CRC is 5-fluorouracil (5FU) and oxaliplatin. The two anticancer drugs mediate their therapeutic effect via DNA damage-triggered signaling. The small molecule reactivating p53 and inducing tumor apoptosis (RITA) is described as an activator of wild-type and reactivator of mutant p53 function, resulting in elevated levels of p53 protein, cell growth arrest, and cell death. Additionally, it has been shown that RITA can induce DNA damage signaling. It is expected that the therapeutic benefits of 5FU and oxaliplatin can be increased by enhancing DNA damage signaling pathways. Therefore, we highlighted the antiproliferative response of RITA alone and in combination with 5FU or oxaliplatin in human CRC cells. A panel of long-term established CRC cell lines (n = 9) including p53 wild-type, p53 mutant, and p53 null and primary patient-derived, low-passage cell lines (n = 5) with different p53 protein status were used for this study. A substantial number of CRC cells with pronounced sensitivity to RITA (IC\(_{50}\)< 3.0 μmol/l) were identified within established (4/9) and primary patient-derived (2/5) CRC cell lines harboring wild-type or mutant p53 protein. Sensitivity to RITA appeared independent of p53 status and was associated with an increase in antiproliferative response to 5FU and oxaliplatin, a transcriptional increase of p53 targets p21 and NOXA, and a decrease in MYC mRNA. The effect of RITA as an inducer of DNA damage was shown by a strong elevation of phosphorylated histone variant H2A.X, which was restricted to RITA-sensitive cells. Our data underline the primary effect of RITA, inducing DNA damage, and demonstrate the differential antiproliferative effect of RITA to CRC cells independent of p53 protein status. We found a substantial number of RITA-sensitive CRC cells within both panels of established CRC cell lines and primary patient-derived CRC cell lines (6/14) that provide a rationale for combining RITA with 5FU or oxaliplatin to enhance the antiproliferative response to both chemotherapeutic agents.
TP53 mutations have been associated with anaplasia in Wilms tumour, which conveys a high risk for relapse and fatal outcome. Nevertheless, TP53 alterations have been reported in no more than 60% of anaplastic tumours, and recent data have suggested their presence in tumours that do not fulfil the criteria for anaplasia, questioning the clinical utility of TP53 analysis. Therefore, we characterized the TP53 status in 84 fatal cases of Wilms tumour, irrespective of histological subtype. We identified TP53 alterations in at least 90% of fatal cases of anaplastic Wilms tumour, and even more when diffuse anaplasia was present, indicating a very strong if not absolute coupling between anaplasia and deregulation of p53 function. Unfortunately, TP53 mutations do not provide additional predictive value in anaplastic tumours since the same mutation rate was found in a cohort of non-fatal anaplastic tumours. When classified according to tumour stage, patients with stage I diffuse anaplastic tumours still had a high chance of survival (87%), but this rate dropped to 26% for stages II–IV. Thus, volume of anaplasia or possible spread may turn out to be critical parameters. Importantly, among non-anaplastic fatal tumours, 26% had TP53 alterations, indicating that TP53 screening may identify additional cases at risk. Several of these non-anaplastic tumours fulfilled some criteria for anaplasia, for example nuclear unrest, suggesting that such partial phenotypes should be under special scrutiny to enhance detection of high-risk tumours via TP53 screening. A major drawback is that these alterations are secondary changes that occur only later in tumour development, leading to striking intratumour heterogeneity that requires multiple biopsies and analysis guided by histological criteria. In conclusion, we found a very close correlation between histological signs of anaplasia and TP53 alterations. The latter may precede development of anaplasia and thereby provide diagnostic value pointing towards aggressive disease.
The regulation of replication is essential to preserve genome integrity. Mms1 is part of the E3 ubiquitin ligase complex that is linked to replication fork progression. By identifying Mms1 binding sites genome-wide in Saccharomyces cerevisiae we connected Mms1 function to genome integrity and replication fork progression at particular G-rich motifs. This motif can form G-quadruplex (G4) structures in vitro. G4 are stable DNA structures that are known to impede replication fork progression. In the absence of Mms1, genome stability is at risk at these G-rich/G4 regions as demonstrated by gross chromosomal rearrangement assays. Mms1 binds throughout the cell cycle to these G-rich/G4 regions and supports the binding of Pif1 DNA helicase. Based on these data we propose a mechanistic model in which Mms1 binds to specific G-rich/G4 motif located on the lagging strand template for DNA replication and supports Pif1 function, DNA replication and genome integrity.
A promising new approach for the treatment of human cancer is the use of oncolytic viruses, which exhibit tumor tropism. One of the top candidates in this area is the oncolytic vaccinia virus (VACV), which has already shown promising results in animal studies and in clinical trials. However, due to discrepancies in both innate and adaptive immunity between mice and men the evaluation of the vaccinia virus’ interactions with the host immune system in mice are not fully conclusive of what is actually happening in human cancer patients after systemic administration of vaccinia virus. Also, ethical and legal concerns as well as risk of potential toxicity limit research involving human patients. Therefore, a good in vivo model for testing interactions between vaccinia virus and human immune cells, avoiding the numerous limitations and risks associated with human studies, could be a humanized mouse model.
LIVP-1.1.1, GLV-2b372, GLV-1h68, GLV-1h375, GLV-1h376 and GLV-1h377 VACVs were provided by Genelux Corporation. GLV-2b372 was constructed by inserting TurboFP635 expression cassette into the J2R locus of the parental LIVP-1.1.1. GLV-1h375, -1h376 and -1h377 VACVs encode the human CTLA4-blocking single-chain antibody (CTLA4 scAb). Performed replication and cytotoxicity assays demonstrated that all six viruses were able to infect, replicate in and kill human tumor cells in virus-dose- and time-dependent fashion. CTLA4 scAb and β-glucuronidase (GusA) expression as well as viral titers in GLV-1h376-infected cells were analyzed by ELISA, β-glucuronidase assay and standard plaque assay, respectively, and compared. An excellent correlation with correlation coefficients R2>0.9806 were observed. GLV-1h376-encoded CTLA4 scAb was successfully purified from supernatants of infected CV-1 cells and demonstrated in vitro affinity to its human CTLA4 target and lack of cross-reactivity to mouse CTLA4. CTLA4 scAb functionality was confirmed in Jurkat cells. LIVP-1.1.1, GLV-2b372, GLV-1h68 and GLV-1h376 were next studied in non-tumorous and/or tumor-bearing humanized mice.
It was demonstrated that injection of human CD34+ stem cells into the liver of preconditioned newborn NSG mice let to a successful systemic reconstitution with human immune cells. CD19+ B cells, CD4 and CD8 single positive CD3+ T cell, NKp46+CD56- and NKp46+CD56+ NK cells as well as CD33+ myeloid cells developed. At early time points after engraftment, majority of the human hematopoietic cells detected in the mouse blood were CD19+ B cells and only a small portion were CD3+ T cells. With time a significant change in CD19+/CD3+ ratio was reported with a decrease of B cells and an increase of T cells. Implantation of A549 cells under the skin of those humanized NSG mice resulted in a progressive tumor growth, described for the first time in this thesis. Successful colonization of subcutaneous A549 tumors with VACVs was visualized and demonstrated by detection of virus-mediated TurboFP635 and GFP expression as well as by standard plaque assay and immunohistochemistry. The human CD45+ cell population in tumors was represented mainly by NKp46+CD56bright NK cells and a large portion of activated CD4+ and cytotoxic CD8+ T cells. However, no significant differences were observed between control and LIVP-1.1.1-infected tumors, suggesting that the recruitment of NK and activated T cells were more tumor tissue specific than virus-dependent. Unfortunately, virus-mediated CTLA4 scAb expression in the GLV-1h376-infected tumors was also not able to significantly increase activation of T cells compared to control and GLV-1h68-treated mice. Importantly, ELISA, β-glucuronidase and standard plaque assays showed an excellent correlation with correlation coefficients R2>0.9454 between CTLA4 scAb, GusA concentrations and viral titers in tumor samples from those GLV-1h376 treated mice.
T cells isolated from the spleens of such control or GLV-1h68- or -1h376-treated A549 tumor-bearing mice were functional and could successfully be activated with human T cells activation beads. However, although no significant difference was observed between the three mouse groups, a slightly higher percentage of the GLV-1h376-treated mice-derived T cells were expressing CD25 and producing IFN-ɣ after ex vivo activation, probably due to the CTLA4 blockade by the virus-encoded CTLA4 scAb in the GLV-1h376-treated mice. Also, slightly higher levels of IL-2 were detected in the culture supernatant of those splenocytes compared to control samples. In contrast, T cells from all three mouse groups were not able be activated by A549 tumor cells ex vivo.
Our model has the specific advantage that tumors develop under the skin of the humanized mice, which allows accurate monitoring of the tumor growth and evaluation of the oncolytic virotherapy. Therefore it is important to choose the right approaches for its further improvement.
Epicardium-derived cells (EPDC) and atrial stromal cells (ASC) display cardio-regenerative potential, but the molecular details are still unexplored. Signals which induce activation, migration and differentiation of these cells are largely unknown. Here we have isolated rat ventricular EPDC and rat/human ASC and performed genetic and proteomic profiling. EPDC and ASC expressed epicardial/mesenchymal markers (WT-1, Tbx18, CD73,CD90, CD44, CD105), cardiac markers (Gata4, Tbx5, troponin T) and also contained phosphocreatine. We used cell surface biotinylation to isolate plasma membrane proteins of rEPDC and hASC, Nano-liquid chromatography with subsequent mass spectrometry and bioinformatics analysis identified 396 rat and 239 human plasma membrane proteins with 149 overlapping proteins. Functional GO-term analysis revealed several significantly enriched categories related to extracellular matrix (ECM), cell migration/differentiation, immunology or angiogenesis. We identified receptors for ephrin and growth factors (IGF, PDGF, EGF, anthrax toxin) known to be involved in cardiac repair and regeneration. Functional category enrichment identified clusters around integrins, PI3K/Akt-signaling and various cardiomyopathies. Our study indicates that EPDC and ASC have a similar molecular phenotype related to cardiac healing/regeneration. The cell surface proteome repository will help to further unravel the molecular details of their cardio-regenerative potential and their role in cardiac diseases.